SCHEMBL810744

SCHEMBL810744

COCOc1ccc2ccccc2c1-c1c(O)ccc2ccccc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.53
MAPT P10636 4/20 0.53
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
CETP P11597 2/20 0.42
CYP1A2 P05177 3/20 0.41
HSD17B10 Q99714 3/20 0.41
CYP2C19 P33261 2/20 0.41
CYP2C9 P11712 1/20 0.41
ALDH1A1 P00352 3/20 0.41
HIF1A Q16665 2/20 0.41
ALOX12 P18054 1/20 0.41
PHLPP2 Q6ZVD8 1/20 0.41
PTPN22 Q9Y2R2 1/20 0.41
KDM4E B2RXH2 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
GAA P10253 1/20 0.39
TAAR1 Q96RJ0 1/20 0.39
PTGS2 P35354 1/20 0.39
KCNH2 Q12809 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29967356 1.00 ALOX5 (0.53) ALOX5MAPTMEN1KMT2ACETP
SCHEMBL1446528 0.91 MAPT (0.63) ALOX5MAPTMEN1KMT2AHSD17B10
SCHEMBL29820187 0.91 MAPT (0.63) ALOX5MAPTMEN1KMT2AHSD17B10
SCHEMBL26736125 0.84 ALOX5 (0.55) ALOX5MAPTMEN1KMT2ACYP1A2
SCHEMBL31043299 0.83 MAPT (0.54) ALOX5MAPTMEN1KMT2ACYP1A2
SCHEMBL6563131 0.82 MAPT (0.79) ALOX5MAPTMEN1KMT2ACETP
SCHEMBL30785795 0.82 MAPT (0.79) ALOX5MAPTMEN1KMT2ACETP
SCHEMBL810748 0.82 MAPT (0.53) ALOX5MAPTMEN1KMT2AALDH1A1
SCHEMBL17148017 0.81 MAPT (0.49) ALOX5MAPTMEN1KMT2APTGS2
SCHEMBL30560666 0.81 MAPT (0.46) ALOX5MAPTCETPCYP1A2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117486815-A Chiral fluorescent probe and preparation method and application thereof 中国药科大学 2024-02-02 CN claimed
CN-113233966-B Chiral fluorescence sensor, preparation method thereof and application thereof in chiral amino acid recognition 中国药科大学 2022-03-08 CN claimed
CN-113233966-A Chiral fluorescence sensor, preparation method thereof and application thereof in chiral amino acid recognition 中国药科大学 2021-08-10 CN claimed
EP-0915073-B1 PROCESS FOR PRODUCING OPTICALLY ACTIVE ISOMERS OF TRICYCLIC COMPOUNDS TORAY INDUSTRIES (JP) 2003-08-13 EP claimed
CN-117486815-A Chiral fluorescent probe and preparation method and application thereof 中国药科大学 2024-02-02 CN disclosed
CN-110790645-A Amphipathic binaphthyl derivative containing dihydroxy, preparation method thereof and application of derivative in distinguishing chiral cyclohexanediamine gas 陕西师范大学 2020-02-14 CN disclosed
CN-107814729-A A kind of chiral aromatic amine compounds and preparation method thereof 中国科学技术大学 2018-03-20 CN disclosed
US-7928257-B2 Method for producing optically active aziridine compounds and amine compounds as well as complexes and their intermediates used in this method JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2011-04-19 US disclosed
US-7897819-B2 Method for producing optically active aziridine compounds and amine compounds as well as complexes and their intermediates used in this method JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2011-03-01 US disclosed
US-7897819-B2 Method for producing optically active aziridine compounds and amine compounds as well as complexes and their intermediates used in this method JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2011-03-01 US disclosed
US-7754899-B2 Method for producing optically active aziridine compounds and amine compounds as well as complexes and their intermediates used in this method JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2010-07-13 US disclosed
US-7754899-B2 Method for producing optically active aziridine compounds and amine compounds as well as complexes and their intermediates used in this method JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2010-07-13 US disclosed
US-20100113835-A1 Method for producing optically active aziridine compounds and amine compounds as well as complexes and their intermediates used in this method JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2010-05-06 US disclosed
US-20100113815-A1 Method for producing optically active aziridine compounds and amine compounds as well as complexes and their intermediates used in this method JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2010-05-06 US disclosed
US-20100113835-A1 Method for producing optically active aziridine compounds and amine compounds as well as complexes and their intermediates used in this method JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2010-05-06 US disclosed
US-20080081916-A1 Method for Producing Optically Active Aziridine Compounds and Amine Compounds as Well as Complexes and their Intermadiates Used in this Method JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2008-04-03 US disclosed
US-20080081916-A1 Method for Producing Optically Active Aziridine Compounds and Amine Compounds as Well as Complexes and their Intermadiates Used in this Method JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2008-04-03 US disclosed
EP-0915073-B1 PROCESS FOR PRODUCING OPTICALLY ACTIVE ISOMERS OF TRICYCLIC COMPOUNDS TORAY INDUSTRIES (JP) 2003-08-13 EP disclosed
US-6103914-A Method of producing optically active material of tricyclic compound TORAY INDUSTRIES, INC. (JP) 2000-08-15 US disclosed
EP-0915073-A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE ISOMERS OF TRICYCLIC COMPOUNDS TORAY INDUSTRIES, INC. (JP) 1999-05-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080081916-A1 Method for Producing Optically Active Aziridine Compounds and Amine Compounds as Well as Complexes and their Intermadiates Used in this Method INTS9, RAD54L, CD99 ALOX5 3545/4885MAPT 3728/4885MEN1 983/4885
US-20100113815-A1 Method for producing optically active aziridine compounds and amine compounds as well as complexes and their intermediates used in this method RAD54L, ATXN2L, CD99 ALOX5 3724/4885MAPT 3282/4885MEN1 1185/4885
US-20100113835-A1 Method for producing optically active aziridine compounds and amine compounds as well as complexes and their intermediates used in this method RAD54L, ATXN2L, CD99 ALOX5 3724/4885MAPT 3282/4885MEN1 1185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.